RA Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $109M | Hold |
|
|||||
|
2025
Q2 | $190M | Hold |
|
|||||
|
2025
Q1 | $137M | Hold |
|
|||||
|
2024
Q4 | $115M | Hold |
|
|||||
|
2024
Q3 | $157M | Hold |
|
|||||
|
2024
Q2 | $92.4M | Hold |
|
|||||
|
2024
Q1 | $111M | Buy |
|
|||||
|
2023
Q4 | $51.8M | Hold |
|
|||||
|
2023
Q3 | $35.8M | Buy |
|
|||||
|
2023
Q2 | $20.2M | Hold |
|
|||||
|
2023
Q1 | $19.6M | Hold |
|
|||||
|
2022
Q4 | $25.7M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $11.6M | Hold |
|
|||||
|
2021
Q3 | $17.4M | Hold |
|
|||||
|
2021
Q2 | $53.8M | Hold |
|
|||||
|
2021
Q1 | $76M | Hold |
|
|||||
|
2020
Q4 | $80.7M | Buy |
|